NCT05112289 - A Study to Evaluate White Matter Hyperintensities in Migraine | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 16, 2021

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions

MigraineSmall Vessel Ischemic DiseaseMultiple Sclerosis

Interventions

DIAGNOSTIC_TEST

Brain Neuroimaging

Non-invasive magnetic resonance imaging sequences will investigate metabolic signatures unique to migraine WMH. Imaging data will be used for development of artificial intelligence (AI) algorithms to classify the cause of WMHs.

Trial Locations (1)

85054

Mayo Clinic in Arizona, Phoenix